(428 days)
Not Found
No
The document describes rechargeable batteries and battery packs for medical devices. The focus is on their physical properties, electrical performance, safety, and comparison to predicate devices. There is no mention of AI or ML in the intended use, device description, testing protocols, or performance studies.
No.
The device described is a rechargeable battery and battery pack designed to power various medical devices; it does not directly provide a therapeutic effect or diagnosis.
No
Explanation: The device described is a rechargeable battery intended to power medical devices. Its function is to provide power, not to diagnose medical conditions or analyze patient data. The testing mentioned in the description refers to the battery's performance and safety, not diagnostic capabilities.
No
The device description clearly states that the device is a physical battery or battery pack, which is a hardware component. The testing protocols also describe physical testing of these hardware components.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use/Indications for Use: The intended use is clearly stated as "To power the functions of various devices for which batteries or battery packs are configured." This describes a power source for medical equipment, not a device used to examine specimens derived from the human body for the purpose of providing information for the diagnosis, monitoring, or treatment of disease.
- Device Description: The description focuses on the battery's function as a power source for medical equipment, its technical specifications (voltage, capacity, chemistry), and its role in maintaining system performance and reliability. There is no mention of analyzing biological samples or providing diagnostic information.
- Lack of IVD-Specific Information: The document does not contain any of the typical characteristics of an IVD submission, such as:
- Mentions image processing, AI, DNN, or ML related to diagnostic analysis.
- Input Imaging Modality or Anatomical Site related to diagnostic procedures.
- Description of training or test sets for diagnostic algorithms.
- Key Metrics like Sensitivity, Specificity, PPV, NPV, which are crucial for evaluating diagnostic performance.
- Predicate Devices: The predicate devices listed are all medical devices that require power (defibrillators, monitors, ECGs, etc.), not IVDs.
In summary, the device is a power source for medical equipment. While it is a critical component for the proper functioning of those medical devices, it does not perform any diagnostic function itself. Therefore, it does not meet the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
To power the functions of various devices for which batteries or battery packs are configured.
Since rechargeable batteries and battery packs are "device specific" and are designed to operate and fit into the equipment for which they were manufactured only qualified personnel should evaluate, test, charge, or install these devices.
Battery Packs are is shipped only to customers who request a replacement battery for a particular device or to replace a competitor's battery. The biomedical equipment technician therefore knows the intended use is as a replacement battery.
Product codes (comma separated list FDA assigned to the subject device)
DPS, LDD, DRT, MHX, DXN, MWI, LOS, DSI, MLD, MSX, DQK, DXH, FLL, DQA, DSJ, DSK, DSF, BZO
Device Description
Batteries have become a critical component in many medical devices. As more devices are computerized and more have become mobile, batteries play an important part in system performance and reliability. Medical batteries are treated as a piece of medical equipment, they are entered as an asset into the facilities equipment database and our included in the preventative maintenance schedule. The end use of the equipment is used to establish the frequency for preventative maintenance. Both the recommendation of the manufacturer of the medical device and the battery spec sheet from the battery manufacturer help establish the maintenance protocol.
Anybattery C2 Rechargeable batteries and battery packs are utilized as a primary direct current (d-c) power source or as a standby or backup d-c power source for portable as well as stationary medical equipment.
Anybattery C2 Rechargeable batteries and battery packs either the primary or secondary source of power and they retain critical parameters and data in the event of power disruption. These batteries range in size, while they are mostly 12-volt, they range in capacity from two-amp hour right up to 36-amp hour batteries.
The performance and life span of a rechargeable battery depends on several factors. Battery operating conditions of temperature, current drain, and charge/discharge method. are taken into account in the design of such batteries. Anybattery's goal is to develop a battery that maintains its battery capacity as high as possible and as long as possible.
There are several types of rechargeable batteries introduced and marketed for medical uses. In this submission are batteries in the Nickel-Based Rechargeable Battery Product Family and the Valve-Regulated Lead-Acid (VRLA) Rechargeable Battery Product Family.
Nickel-Based Rechargeable Battery Product Family
- The Nickel-Cadmium battery (NDC) is the most widely used rechargeable • battery. Its efficient charge and discharge characteristics, reliability and economic nature have made it very popular and widely utilized in the medical industry. Manufacturers have developed nickel-cadmium batteries that can be charged up completely in one hour.
- The Nickel Metal Hydride (NMH) battery is a new technology being-worked on that can provide a 50% increase in energy density compared to Nickel Cadmium batteries. The Lithium battery recently introduced with energy densities of greater than twice that of NiCad batteries.
VRLA Rechargeable Battery Product Family
The Valve-Regulated Lead-Acid (VRLA) battery more commonly known as a sealed battery (SLA) is a type of lead-acid rechargeable battery. Due to their construction, the Gel and AGM types of VRLA can be mounted in any orientation, and do not require constant maintenance. There are three primary types of VRLA batteries, Sealed VR wet cell, AGM and Gel. Gel cells add silica dust to the electrolyte, forming a thick putty-like gel. These are sometimes referred to as "silicone batteries". AGM (absorbed glass mat) batteries feature fiberglass between the battery plates, which serves to contain the electrolyte. Both designs offer advantages and disadvantages compared to conventional batteries and sealed VR wet cells, as well as each other.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Qualified personnel should evaluate, test, charge, or install these devices.
The biomedical equipment technician therefore knows the intended use is as a replacement battery.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Voltage and capacity of battery cells and packs are tested using Vencon UBA Battery Analyzers in the "Test Mode" upon full completion of battery assembly design. This exercises the batteries in order to identify performance characteristics by running them through three (3) full charge/discharge cycles in the NKL based family and two (2) full cycles in the VRLA family. Tests typically take 12~48 hours for each battery pack.
All battery chemistries can be tested using custom test parameters, depending on Quality Control and customer requirements. This allows for various C -Rates, delta V (1:N), and volts-per-cell to be entered into the test protocol the Vencon UBA Software (Reference UBA Test Report Examples - Figures 1 and 2)
Target capacity is the percentage of the battery capacity compared to nominal capacity and serves as a threshold. This threshold, or target capacity, can be set to any desired range (90 - 95% is typical).
Target capacity is a pass/fail mark for design acceptance. Our batteries must meet or exceed a required threshold of 90%, or higher, prior to final design control acceptance. Any samples that do not meet the criteria are rejected. Batch build sheets require 100% >then cutoff voltage, and polarity testing. Subsequently, the entire lot is tested and documented in this manner.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Study Type: Battery Pack Testing, Safety and Performance testing
Sample Size: Not specified for the specific studies, but "Any samples that do not meet the criteria are rejected. Batch build sheets require 100% >then cutoff voltage, and polarity testing. Subsequently, the entire lot is tested and documented in this manner."
Key Results:
- Incoming Inspection: All cells are inspected for correct specification, visible damage, and randomly voltage tested prior to acceptance. Lot numbers recorded. Cases inspected for form, fit, function, and cosmetics.
- Vencon Testing: Voltage and capacity tested using Vencon UBA Battery Analyzers. Three full charge/discharge cycles for Nickel-based, two for VRLA. Tests typically take 12-48 hours per pack. Target capacity (90% or higher, typical 90-95%) is a pass/fail mark for design acceptance. All battery chemistries can be tested with custom parameters.
- Voltage Testing - Completed Packs: All battery packs are tested 100% for correct voltage and polarity prior to shipment. Failing devices are rejected and quarantined.
- Safety and Performance:
- Life cycle: Replacement battery must provide as many or more charge and discharge cycles as the original. Based on IEC61951-2 and IEC 61056-1. Device life shall be 12 months from point of sale.
- Temperature: Replacement battery must function correctly over the same temperature range as the original. Testing done at 0, 25, and 40℃ (32, 77, and 104°F respectively).
- Mechanical & Electrical Component Integrity: Normal testing involves drop tests from 2-3 feet onto a hard, uniform surface. Battery packs inspected for case cracks, cell separation, and electrical/electronic component damage. Root cause analysis performed if damage occurs.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
- Target capacity for design acceptance: 90% or higher (typically 90-95%)
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K913484, K895520, K910754, K760160, K881153, K902288, K012451, K931053, K971436, K141156, K925510, K022537, K984033, K870880, K991735, K964750, K941462, K943959, K946281, K102422, K002248, K983796, K984618, K072217, K011918, K033048, K060167
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2340 Electrocardiograph.
(a)
Identification. An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes entwined around it, overlaid on three human profiles facing right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 14, 2017
Anybattery, Inc. % Claude Berthoin President Denterprise International, Inc./510k FDA Consulting 100 East Granade Blvd., Suite 219 Ormond Beach, Florida 32176
Re: K160667
Trade/Device Name: Anybattery C2 Rechargeable Battery, with list of 28 models attached Regulation Number: 21 CFR 870.2340 Regulation Name: Electrocardiograph Regulatory Class: Class II Product Code: DPS, LOS, LDD, DRT, MHX, DSI, MLD, MSX, MWI, DOK, DXH, FLL, DQA, DSJ, DSK, DSF, BZQ, and DXN Dated: April 5, 2016 Received: April 11, 2017
Dear Claude Berthoin:
This letter corrects our substantially equivalent letter of May 11, 2017.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
1
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
M.A. Wilhelm
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Anybattery, Inc. List of all batteries cleared in K160667
(Total of 28 battery models, due to some batteries being grouped together under one predicate)
Anybattery C2 Rechargeable Batteries in the VRLA Product Family.
- Anybattery 3394 is substantial equivalent to that manufactured by:
- Zoll D-900 defibrillator cleared K913484. .
-
- Anybattery 4028 is substantial equivalent to that manufactured by:
- Hewlett-Packard Pagewriter XLI M1700A & Pagewriter XL M1701A cleared . K895520.
-
- Anybattery 4040 is substantial equivalent to that manufactured by:
- HP 43100 series defibrillator monitors cleared K910754. ●
-
- Anybattery 4043 is substantial equivalent to that manufactured by:
- Hewlett-Packard Monitor, Patient Model 78333A cleared K760160. ●
-
- Anybattery 4494 is substantial equivalent to that manufactured by:
- Physio-Control LifePak 9 Defibrillator & Cardiac Monitor cleared K881153. ●
-
- Anybattery 4494-2 is substantial equivalent to that manufactured by:
- Physio-Control LifePak 9 series defibrillator monitors cleared K902288. ●
-
- Anybattery 4510 is substantially equivalent to that manufactured by:
- Welch Allyn Protocol Propaq cleared K012451. ●
-
- Anybattery 4713-2 is substantial equivalent to that manufactured by:
- Physio-Control Lifepak 10 defibrillator cleared K931053. ●
-
- Anybattery 5349-4 is substantial equivalent to that manufactured by:
- Nihon-Kohden TEC-7511A/TEC-7521A CardioLife Portable Defibrillator & . Accessories cleared K971436.
-
- Anybattery 6558 is e substantial equivalent to that manufactured by:
-
- Anybattery 7714-1 and 7714-2 are substantial equivalent to that manufactured by:
- Colin Pressmate PM2100 VSM cleared K022537. .
-
- Anybattery 8601 is substantial equivalent to that manufactured by:
- Welch Allyn Atlus Monitor cleared K984033. .
3
Anybatterv C2 Rechargeable Batteries in the Nickel-Based Rechargeable Batterv Product Eamily
-
- Anybattery 3777 is substantial equivalent to that manufactured by:
- . Burdick EK10 Series ECG cleared K870880.
-
- Anybattery 4218 is substantial equivalent to that manufactured by
- General Electric MAC Series Electrocardiographs cleared K991735. .
-
- Anybattery 4227 is substantial equivalent to that manufactured by:
- Marquette Eagle 4000 Patient Monitor cleared K964750. .
-
- Anybattery 5960 is substantial equivalent to that manufactured by:
- Schiller AT-5 cleared K941462. ●
-
- Anybattery 6459, 7062-1 and 7062-2 are substantial equivalent to that manufactured by:
- Burdick Eclipse Series ECG cleared K943959 & K946281. ●
-
- Anybattery 7023 is substantial equivalent to that manufactured by:
- General Electric MAC Series Electrocardiographs cleared K991735.
-
- Anybattery 7038 is substantial equivalent to that manufactured by:
- Spacelabs Medical Patient Monitors cleared K102422.
-
- Anybattery 7050 is substantial equivalent to that manufactured by:
- . Critikon Dinamap Pro 1000 Monitor cleared K002248.
-
- Anybattery 7059 is substantial equivalent to that manufactured by:
- BCI Intl., Inc. 6004 NIBP Monitor cleared K983796 & K984618. ●
-
- Anybattery 7171 is substantial equivalent to that manufactured by:
- . Nihon Kohden ECG-1250A Series and ECG-1350A Series ECGs cleared K072217.
-
- Anybattery 7711 is substantial equivalent to that manufactured by:
- Nihon Kohden BSM-2300A Series Bedside Monitor cleared K011918. .
-
- Anybattery 7726 is substantial equivalent to that manufactured by
- CAS Medical 740 Series Monitor cleared K033048. .
-
- Anybattery 7732 is substantial equivalent to that manufactured by:
- Cardiac Science Atria 3100, 6100 cleared K060167. .
4
Indications for Use
510(k) Number (if known) K160667
Device Name
Anybattery Battery Pack
Indications for Use (Describe)
To power the functions of various devices for which batteries or battery packs are configured.
Since rechargeable batteries and battery packs are "device specific" and are designed to operate and fit into the equipment for which they were manufactured only qualified personnel should evaluate, test, charge, or install these devices.
Battery Packs are is shipped only to customers who request a replacement battery for a particular device or to replace a competitor's battery. The biomedical equipment technician therefore knows the intended use is as a replacement battery.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
5
Image /page/5/Picture/1 description: The image shows the logo for "510k FDA Consulting". The logo features a black and white image of an eagle on the left side of the image. To the right of the eagle is the text "510k FDA Consulting" in a large, bold font. Below that text is the phrase "Medical Device Clearance" in a smaller font.
100 East Granada Blvd., Suite 219
Ormond Beach, FL 32176
386-506-8711
510 (k) Summary
I. Submitter/Applicant
Anybattery, Inc. 2605 160th Street West, Unit 116 Rosemount, Minnesota 55068
Phone: 651-423-0555 Point of Contact: Edward J. Speegle, (ed@anybattery.net)
Preparer/Consultant
Denterprise International, Inc. 100 East Granada Blvd., Suite 219 Ormond Beach, FL 32176
Phone: 386-506-8711 Fax: 386-672-4402 Primary Contact: Joyce St. Germain, Regulatory Assistant (joyce@510kfda.com) Secondary Contact: Claude Berthoin, President (joyce@510kfda.com) Preparation Date: March 3, 2016
II. Device Classification
| Trade Name: | Anybattery C2 Rechargeable Battery |
|---|---|
| Common Name: | Box Battery or Pack Battery |
| Submission Type: | 510(k) |
| Regulatory Class: | II |
| Classification Name: | Box Battery, Rechargeable |
| Panel: | Cardiovascular |
6
| Product
| Code | Regulation | Device |
|---|---|---|
| DPS | 21CFR870.2340 | Electrocardiograph |
| LDD | 21CFR870.5300 | Dc-Defibrillator, Low-Energy, (Including Paddles) |
| DRT | 21CFR870.2300 | Monitor, Cardiac (Incl. Cardiotachometer & Rate Alarm) |
| MHX | 21CFR870.1025 | Arrhythmia Detector and Alarms |
| DXN | 21CFR870.113 | System, Measurement, Blood-Pressure, Non-Invasive |
| Monitor, Physiological, Patient (without Arrhythmia | ||
| MWI | 21CFR870.2300 | Detection or Alarms) |
| LOS | Unclassified, pre-amendment device | |
| DSI | 21CFR870.1025 | Arrhythmia Detector and Alarm |
| MLD | 21CFR870.1025 | Arrhythmia Detector and Alarm |
| MSX | 21CFR870.2300 | Cardiac Monitor |
| DQK | 21CFR870.1425 | Programmable Diagnostic Computer |
| DXH | 21CFR870.2920 | Telephone Electrocardiograph Transmitter and Receiver |
| FLL | 21CFR880.2910 | Clinical Electronic Thermometer |
| DQA | 21CFR870.2700 | Oximeter |
| DSJ | 21CFR870.1100 | Blood Pressure Alarm |
| DSK | 21CFR870.1110 | Blood Pressure Computer |
| DSF | 21CFR870.2810 | Paper Chart Recorder |
| BZO | 21CFR868.2375 | Breathing Frequency Monitor |
III. Predicate Device
This submission compares the specifications and functionally of various rechargeable battery packs with those of similar devices that were included as part of the following original predicate devices and submissions.
Anybattery C2 Rechargeable Batteries in the VRLA Product Family.
-
- Anybattery 3394 is substantial equivalent to that manufactured by:
- Zoll D-900 defibrillator cleared K913484. .
-
- Anybattery 4028 is substantial equivalent to that manufactured by:
- Hewlett-Packard Pagewriter XLI M1700A & Pagewriter XL M1701A cleared . K895520.
-
- Anybattery 4040 is substantial equivalent to that manufactured by:
- HP 43100 series defibrillator monitors cleared K910754. .
7
-
- Anybattery 4043 is substantial equivalent to that manufactured by:
- . Hewlett-Packard Monitor, Patient Model 78333A cleared K760160.
-
- Anybattery 4494 is substantial equivalent to that manufactured by:
- . Physio-Control LifePak 9 Defibrillator & Cardiac Monitor cleared K881153.
-
- Anybattery 4494-2 is substantial equivalent to that manufactured by:
- . Physio-Control LifePak 9 series defibrillator monitors cleared K902288.
-
- Anybattery 4510 is substantially equivalent to that manufactured by:
- Welch Allyn Protocol Propaq cleared K012451. ●
-
- Anybattery 4713-2 is substantial equivalent to that manufactured by:
- Physio-Control Lifepak 10 defibrillator cleared K931053. .
-
- Anybattery 5349-4 is substantial equivalent to that manufactured by:
- Nihon-Kohden TEC-7511A/TEC-7521A CardioLife Portable Defibrillator & . Accessories cleared K971436.
-
- Anybattery 6558 is e substantial equivalent to that manufactured by:
-
- Anybattery 7714-1 and 7714-2 are substantial equivalent to that manufactured by:
- Colin Pressmate PM2100 VSM cleared K022537. .
-
- Anybattery 8601 is substantial equivalent to that manufactured by:
- Welch Allyn Atlus Monitor cleared K984033. .
Anybatterv C2 Rechargeable Batteries in the Nickel-Based Rechargeable Battery Product Family
-
- Anybattery 3777 is substantial equivalent to that manufactured by:
- Burdick EK10 Series ECG cleared K870880. .
-
- Anybattery 4218 is substantial equivalent to that manufactured by
- . General Electric MAC Series Electrocardiographs cleared K991735.
-
- Anybattery 4227 is substantial equivalent to that manufactured by:
- Marquette Eagle 4000 Patient Monitor cleared K964750. ●
-
- Anybattery 5960 is substantial equivalent to that manufactured by:
- . Schiller AT-5 cleared K941462.
8
- Anybattery 6459, 7062-1 and 7062-2 are substantial equivalent to that manufactured by:
- Burdick Eclipse Series ECG cleared K943959 & K946281. ●
-
- Anybattery 7023 is substantial equivalent to that manufactured by:
- General Electric MAC Series Electrocardiographs cleared K991735. ●
-
- Anybattery 7038 is substantial equivalent to that manufactured by:
- Spacelabs Medical Patient Monitors cleared K102422. ●
-
- Anybattery 7050 is substantial equivalent to that manufactured by:
- . Critikon Dinamap Pro 1000 Monitor cleared K002248.
-
- Anybattery 7059 is substantial equivalent to that manufactured by:
-
- Anybattery 7171 is substantial equivalent to that manufactured by:
- Nihon Kohden ECG-1250A Series and ECG-1350A Series ECGs cleared ● K072217.
-
- Anybattery 7711 is substantial equivalent to that manufactured by:
- Nihon Kohden BSM-2300A Series Bedside Monitor cleared K011918. .
-
- Anybattery 7726 is substantial equivalent to that manufactured by
- CAS Medical 740 Series Monitor cleared K033048. ●
-
- Anybattery 7732 is substantial equivalent to that manufactured by:
- Cardiac Science Atria 3100, 6100 cleared K060167. ●
IV. Device Description
Batteries have become a critical component in many medical devices. As more devices are computerized and more have become mobile, batteries play an important part in system performance and reliability. Medical batteries are treated as a piece of medical equipment, they are entered as an asset into the facilities equipment database and our included in the preventative maintenance schedule. The end use of the equipment is used to establish the frequency for preventative maintenance. Both the recommendation of the manufacturer of the medical device and the battery spec sheet from the battery manufacturer help establish the maintenance protocol.
Anybattery C2 Rechargeable batteries and battery packs are utilized as a primary direct current (d-c) power source or as a standby or backup d-c power source for portable as well as stationary medical equipment.
Anybattery C2 Rechargeable batteries and battery packs either the primary or secondary source of power and they retain critical parameters and data in the event of power
9
disruption. These batteries range in size, while they are mostly 12-volt, they range in capacity from two-amp hour right up to 36-amp hour batteries.
The performance and life span of a rechargeable battery depends on several factors. Battery operating conditions of temperature, current drain, and charge/discharge method. are taken into account in the design of such batteries. Anybattery's goal is to develop a battery that maintains its battery capacity as high as possible and as long as possible.
There are several types of rechargeable batteries introduced and marketed for medical uses. In this submission are batteries in the Nickel-Based Rechargeable Battery Product Family and the Valve-Regulated Lead-Acid (VRLA) Rechargeable Battery Product Family.
Nickel-Based Rechargeable Battery Product Family
- The Nickel-Cadmium battery (NDC) is the most widely used rechargeable • battery. Its efficient charge and discharge characteristics, reliability and economic nature have made it very popular and widely utilized in the medical industry. Manufacturers have developed nickel-cadmium batteries that can be charged up completely in one hour.
- The Nickel Metal Hydride (NMH) battery is a new technology being-worked on that can provide a 50% increase in energy density compared to Nickel Cadmium batteries. The Lithium battery recently introduced with energy densities of greater than twice that of NiCad batteries.
VRLA Rechargeable Battery Product Family
The Valve-Regulated Lead-Acid (VRLA) battery more commonly known as a sealed battery (SLA) is a type of lead-acid rechargeable battery. Due to their construction, the Gel and AGM types of VRLA can be mounted in any orientation, and do not require constant maintenance. There are three primary types of VRLA batteries, Sealed VR wet cell, AGM and Gel. Gel cells add silica dust to the electrolyte, forming a thick putty-like gel. These are sometimes referred to as "silicone batteries". AGM (absorbed glass mat) batteries feature fiberglass between the battery plates, which serves to contain the electrolyte. Both designs offer advantages and disadvantages compared to conventional batteries and sealed VR wet cells, as well as each other.
V. Indications for Use [Same as Intended Use]
To power the functions of various devices for which batteries or battery packs are configured.
Since rechargeable batteries and battery packs are "device specific" and are designed to operate and fit into the equipment for which they were manufactured only qualified personnel should evaluate, test, charge, or install these devices.
10
Battery Packs are shipped only to customers who request a replacement battery for a particular device or to replace a competitor's battery. The biomedical equipment technician therefore knows the intended use is as a replacement battery.
VI. Comparison of Technological Characteristics
The design components and functionality of the various batteries and battery packs included in this submission are similar to those of their predicate devices. Typical cell chemistries are Sealed -Lead Acid (SLA), Nickel-Cadmium (NiCad), and Nickel-Metal Hydride (NiMH). Both the new devices and the predicate devices provide a means of supplying electrical power through chemical reaction. The energy provided depends upon the voltage and capacity rating of a particular pack and the amount of current used by the device which they are installed. The performance and life span of the new devices and the predicate devices depends on operating conditions of temperature, current drain, and the charge/discharge method (if applicable). These parameters are taken into account in designing such batteries. The goal of all battery manufacturers is to develop batteries and battery packs that maintain capacity for as high and as long as possible. In comparison analysis, OEM Battery Packs (Predicate devices) set the benchmark and the Anybattery batteries replacement devices met and/or exceed the benchmark.
VII. Performance Data
Battery Pack Testing
General Protocol. The same battery testing protocol is used by the manufacturers of the predicate devices and the new devices.
Incoming Inspection
All cells are inspected for correct specification, visible damage, and randomly voltage tested prior to acceptance. The lot numbers are recorded for tracking purposes should any fail during final assembly and inspection activities. Cases are also inspected for form, fit, function, and cosmetics.
Vencon Testing
Voltage and capacity of battery cells and packs are tested using Vencon UBA Battery Analyzers in the "Test Mode" upon full completion of battery assembly design. This exercises the batteries in order to identify performance characteristics by running them through three (3) full charge/discharge cycles in the NKL based family and two (2) full cycles in the VRLA family. Tests typically take 12~48 hours for each battery pack.
All battery chemistries can be tested using custom test parameters, depending on Quality Control and customer requirements. This allows for various C -Rates, delta V (1:N), and volts-per-cell to be entered into the test protocol the Vencon UBA Software (Reference UBA Test Report Examples - Figures 1 and 2)
11
Target capacity is the percentage of the battery capacity compared to nominal capacity and serves as a threshold. This threshold, or target capacity, can be set to any desired range (90 - 95% is typical).
Target capacity is a pass/fail mark for design acceptance. Our batteries must meet or exceed a required threshold of 90%, or higher, prior to final design control acceptance. Any samples that do not meet the criteria are rejected. Batch build sheets require 100% >then cutoff voltage, and polarity testing. Subsequently, the entire lot is tested and documented in this manner.
Battery packs are shipped in various states of dis-charge. There are specific DOT, FAA, and EPA regulations and guidelines that address these concerns.
Voltage Testing - Completed Packs
All Battery Packs are tested 100% for correct voltage and polarity prior to shipment. Those devices that fail are rejected and quarantined.
Safety and Performance
Safety and performance testing of battery packs are performed to ensure that these devices meet all functional requirements and performance specifications. In comparison analysis, OEM Battery Packs set the benchmark. Replacement devices must meet or exceed these benchmark results consistently.
Concerns that are addressed during bench test comparison analysis are:
-
. Life cycle
The replacement battery must provide as many or more charge and discharge cycles as the original. This is an ongoing process and is not part of the standard QC final inspection protocol. The cycle life is based on cycles under criteria set forth in IEC61951-2 Secondary cells and batteries containing alkaline or other non-acid electrolytes - Portable sealed rechargeable single cells. Part 2: Nickel-Metal hydride and IEC 61056-1 General purpose lead-acid batteries (valve-regulated types) Part 1: General requirements, functional characteristics - Methods of test. As there is no internationally recognized shelf life determination, it is determined the device life shall be 12 months from point of sale. -
Temperature •
The replacement battery must function correctly over the same temperature range as compared to the original. Testing is done at 0, 25, and 40℃ (32, 77, and 104°F respectively). -
. Mechanical & Electrical Component Integrity
Normal testing would involve drop tests from a predetermined height, usually 2-3 feet, onto a hard, uniform surface. Battery packs are inspected for case cracks, cell separation, and electrical/electronic component damage. Root cause analysis is performed should any damage occur.
12
VIII. Conclusion
In conclusion, Anybattery C2 Rechargeable battery packs are the substantial equivalent to the predicate devices. Anybattery C2 Rechargeable batteries and battery packs are the substantial equivalent in design, function and intended use to their predicate devices. In comparison analysis, the predicate batteries and battery packs set the benchmark and Anybattery C2 Rechargeable batteries and battery packs met or exceed the predicate devices in design and functionality, material, safety and performance, packing protocol, principal of operation, mechanical capacity, and physical properties, i.e., dimension, weight, voltage, discharge capacity, impedence and storage and device life. It is deemed after a comprehensive comparison analysis that Anybattery C2 Rechargeable batteries and battery packs are the substantial equivalent to the predication devices.